Hua Da Smart Manufacturing (688114.SH) expects to improve profit quality in the first half of 2025: the net profit attributable to the parent is expected to decrease by more than 65%, and the non-net profit attributable to the parent is expected to decrease by more than 37%.

According to the Zhitong Finance APP, after the market on August 22nd, Huada Genomics (688114.SH) released its mid-term performance report for 2025. The report shows that in the first half of 2025, the company achieved a main business income of 1.091 billion yuan, with a net profit attributable to the owner of the parent company decreasing by 65.28% year-on-year. The company's long-read sequencing business, as its core business segment, saw a record high in the first half of the year, with over 700 new instrument sales, a year-on-year increase of 60.35%.